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Microbiology in the “-omics”
era: a report on the 2nd FEMS
Congress (Madrid, 4-8 July
2006)
Summoned by the FEMS (Federation of European Microbio-
logical Societies), about 1500 European microbiologists met
in Madrid from July 4–8, 2006, to attend the organization’s
2nd Congress. The comprehensive scientific program cov-
ered the wide spectrum of areas influenced by microbial life
in the biosphere, including bio-
medicine and biotechnology.
The presentations ranged from
the most basic research to high-
ly specialized applications (for
instance, the contribution of
microbes to nanotechnology).
The motto of the official T-shirt
of the Congress, “I live in a
microbial world”, served as a re-
minder of the central role of
microorganisms in the develop-
ment and maintenance of life on
Earth, and as an invitation to all
of society to share with microbio-
logists the implications of that
reality. Actually, given the
intense pace of the Congress, it
is hard to believe that our thor-
ough exploration of the micro-
scopic world began relatively
recently (about 150 years ago).
After a welcoming “Fermentation
Party,” conceived to acquaint our
international guests with the rich-
ness and variety of Spanish fermented food, attendants had the
opportunity to partake in the excitement of sharing the
progress in microbial knowledge, as presented in five plenary
lectures, 22 symposia, and 19 workshops. Researchers from 63
countries presented a wealth of data that confirmed the cur-
rent good health of microbiology. Most of the research pre-
sented in Madrid fit into three broad mainstream categories:
health (the study, treatment, and prevention of infectious dis-
eases), environment (microbial ecology, evolution, and adap-
tation to different habitats), and biotechnology (microbiolog-
ical knowledge for industrial uses, including food prepara-
tion and safety). Apparently, none of these categories has
escaped the rush of the current post-genomic revolution. The
scientific committee of the Congress, co-chaired by Eliora
Ron (current FEMS president) and César Nombela (former
FEMS president and head of the Local Organizing Com-
mittee on behalf of the Spanish Society for Microbiology,
SEM), was far-sighted enough to put the focus on the novel
“-omic” perspective, to which microbiology is critically con-
tributing: genomics, proteomics, metabolomics, biomics, etc.
This plunge into the future was best be appreciated by first
examining the past, as Ernst Rietschel did in his fascinating
retrodiagnosis of the infectious
diseases that ended the lives of
several of the world’s greatest
musicians (Rossini, Bizet, and
Mahler, among others).
Good times for pathoge-
nomics. It would be impossi-
ble to list and comment here on
all the presentations at the
Congress, but I would like to
draw attention to a few of the
highlights. In the field of med-
ical bacteriology, the implica-
tions of pathogenomics, a post-
genomic approach devoted to
mining and functionally inter-
preting data obtained from
sequencing the whole genomes
of pathogenic bacteria. Hacker,
who is director of the Center
for Infectious Diseases at the
University of Würzburg, Ger-
many, was awarded the FEMS-
Lwoff Award, named after the
distinguished microbiologist André M. Lwoff (1902-1994)
[1]. This is the most prestigious honor bestowed by FEMS,
and was established to mark the 25th anniversary of the
Federation, six years ago [2]. For the occasion, Hacker, held
a lecture on the evolution of bacterial pathogens, mostly
based on research carried out by his team on Escherichia coli
(so christened after the eminent Würzburg microbiologist
Theodor Escherich, 1857-1911).
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Early in the meeting it had already become clear that
pathogenomics is one of the landmarks of current research in
microbiology. At the “Frontiers in Pathogenomics” work-
shop, a European network of projects that focus on this pro-
ductive field was created and is scheduled to become opera-
tive in 2007. The primary goal of pathogenomics is to use the
overwhelming wealth of information provided by genome
sequencing to discover the genes responsible for infectious
diseases. Perhaps the most powerful tool for this purpose is
comparative genomics. The potential of such an approach is
emerging from its infancy, as evidenced by the novel DNA
sequencers based on PCR in emulsion and the pyrosequenc-
ing-based strategies, both of which were presented by com-
mercial exhibitors during the Congress. These machines can
sequence a genome of 2 million bases in a single run of 5½ h,
a result that would take months with the current technology.
The team led by Hacker has contributed to the post-genomic
era by comparing the whole genomes of certain isolates of E.
coli, namely, the harmless commensal inhabitants of the
human body, with aggressive pathogenic strains. Their
efforts resulted in the discovery of seven pathogenicity
islands in an isolate causing severe infections of the urinary
tract. The genetic information contained in these islands is
yielding amazing insight into the molecular mechanisms of
bacterial virulence. Moreover, the evolution of pathogens
and commensals is written in the structure and nature of these
genomic islands. Hacker also presented an intriguing hypoth-
esis on the dynamics of bacterial evolution, honoring
Darwin’s theories but pushing them one step forward: there
is a fast-developing “microevolution” that gradually feeds
the requirements of natural selection to drive the macroevo-
lution of new, more competent species.
I could not close this brief mention of the contribution of
post-genomics to our advances against infections disease
without noting the use of “reverse genetics” in vaccine devel-
opment. The Italian researcher Guido Grandi reported major
advances based on this strategy in the development of vac-
cines against meningitis and β-hemolytic streptococci. 
Avian flu: the threat is in the air. Virology was also
broadly represented at the meeting, with discussions of emer-
gent pathogens taking the lead. By chance, on July 7, 2006,
the first case in the Iberian peninsula of highly pathogenic
H5N1 avian influenza virus was reported and involved a bird
found dead in its natural environment near the city of Vitoria
(Basc Country). At the same time that the Spanish health
authorities made the report public, experts on the field from
around the world were attending the “Emerging Infections”
symposium in Madrid. H5N1 was inevitably being debated.
When authorities on influenza, such as Albert Osterhaus,
Adolfo García Sastre, Alan Hay, and Brian Mahy, were asked
by journalists about measures to be taken to avoid spreading
of the virus and its threat to human health, they all agreed on
a major essential point: There is no real threat unless the virus
is transmitted to domestic fowl by infected wild migrating
birds, which have acted as reservoirs of the disease, as has
massively been the case in some regions of Asia. All meas-
ures to be adopted at this stage of the situation in Europe
should be directed at avoiding this form of transmission.
Infection of poultry would not only have important econom-
ic consequences, but might also constitute a serious risk for
farm workers and potential consumers. We must remember
that every case of human infection is a chance given to the
virus to mutate into a form transmissible from human to
human. After recovery of the genome of the deadly 1918
pneumonia virus, which killed around 40 million people,
researchers hypothesized that a mutational event of this kind
was responsible for the historic pandemic episode. A second
scenario of risk involves the creation of a human transmissi-
ble virus: in this case, a person (or an animal sharing a habi-
tat with humans) would be simultaneously infected with a
common flu virus and a highly pathogenic avian flu virus,
followed by the reassortment of both viral genomes which
could result in a highly pathogenic human flu virus.
According to epidemiologists, this was the likely scenario in
two other human viral pandemics of the 20th century, i.e.,
Asian flu (1957) and Hong Kong flu (1968).
Osterhaus (from the Institute of Virology, Rotterdam)
emphasized the lessons to be learned from the incidents of
the last decade involving transmission to humans of highly
pathogenic avian influenza, namely the H5 and H7 types.
Regarding H5N1, it is well-known that, over the last two
years, around 230 people have acquired the avian virus in
Asia after contact with sick birds, and that 130 of them died.
However, human to human transmission has not been strict-
ly proven, except perhaps in one case. However, an H7N7
outburst in the Netherlands in 2003 caused 78 cases of
human conjunctivitis and, occasionally, more severe disease
(including one fatal case) in farm workers and veterinarians;
besides, transmission to familiars was reported. Osterhaus
also mentioned that cats fed with infected birds developed
fatal systemic disease, so that felines should be controlled in
the case of an outbreak of avian influenza. Mahy (Centers for
Disease Control, USA) closed the Congress by pointing out
that H5N1 is the most important candidate for a potential
pandemic threat. He agreed that massive vaccination of poul-
try would be the best long-term prevention measure. In this
sense, the vaccine developed by the García Sastre laboratory
(Mount Sinai School of Medicine, New York), by means of
engineering the vaccinal form of Newcastle virus, aims to act
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as a dual vaccine that with one shot protects birds against
both Newcastle disease and the highly virulent H5N1. An
important advantage of this vaccine over those developed
from attenuated influenza virus is that it would allow vacci-
nated animals to be distinguished from those that have been
naturally infected.
Bioremediation at its best. Environmental microbiol-
ogy is one of the fields taking advantage of the post-genom-
ic era. A major topic at the Congress was bioremediation, that
is, the use of microbial metabolic capabilities to eradicate
recalcitrant chemicals released to the biosphere by our
obnoxious industrial activity. The Spanish researcher Víctor
de Lorenzo reminded us that in our daily life we deal with no
less than 40,000 xenobiotics and that microorganisms have
not yet had the chance to evolve into efficient and sufficient-
ly avid metabolizers to meet the challenge posed by them.
Nevertheless, as official scavengers and recyclers of our
planet, they are our only hope if we are to attempt decontam-
inating it. We already know that microbial consortia are able
to feed on truly recalcitrant compounds, opening a door of
hope for our future. De Lorenzo proposed that we envision
microbial consortia, mostly composed of as-yet-unidentified
life forms, as “landscapes” of catalytic activities upon which
a given compound flows towards the valleys that will lead it
to mineralization. Based on this rationale, his laboratory has
worked on the development of bioinformatic tools that inte-
grate all known catalytic abilities, which, in turn, can be
applied in a quest for “shortcuts” in a universal enzymatic
landscape. By this means, it would even be possible to pre-
dict the biodegradability or recalcitrance of putative novel
xenobiotics that organic chemistry could at some time gener-
ate. One of the achievements of de Lorenzo and his team has
been the isolation of genes responsible for enzymatic activi-
ties involved in the removal of chlorinated compounds.
Metagenomics, also known as biomics, will help microbiol-
ogists in the search for these activities regardless of the
microorganism of origin. Such efforts are sowing the seeds
for systems biology, a frontier science between computation
and biology that aims to predict the behavior of living sys-
tems. Peer Bork (European Laboratory for Molecular Biol-
ogy, Heidelberg, Germany) introduced the concept of com-
parative metagenomics, a perspective that will no doubt
eventually shed light on the adaptation of microbial consor-
tia to different environments. Bork also predicted that in the
future cellular systems will be analyzed in 4D; that is, order-
ing the networks established by systems biology in the three
dimensions of space and adding the parameter time. He sup-
ported his prediction with some very interesting preliminary
data obtained from the minimum genome of Mycoplasma.
* * *
Of the many “take-home” messages of the Congress, perhaps
“enroll the -omics wave” should head the list. No one can
ignore that microbiology is currently in a new Golden Age,
inaugurated by the ability to functionally analyze genomes
and metagenomes. There is not the slightest doubt that your
favorite research field has already been inundated by the
“-omics wave.” Join the trend or be marooned in the 20th
century and accused of reductionism! And consider that only
50 years ago you had to isolate your microorganism of inter-
est in pure culture in order to be recognized as a microbiolo-
gist. Today, this is no longer necessary; instead, the gates of
microbiology will be open to you if you can manage to obtain
the microorganism’s genome, print a microarray for its tran-
scriptomic analyses, set up the necessary proteomic tools
and, ultimately, use your computer to predict the bacterium’s
behavior. It is now time to integrate the wealth of knowledge
that has accumulated from these approaches, and to use the
“-omics wave” to take advantage of all that microbiology has
to offer humanity. 
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Taking the pulse of Latin
American microbiology: 
the 18th ALAM Congress
(Pucón, 23-26 October 2006)
Over 600 scientists from sixteen countries (Argentina, Brazil,
Chile, Colombia, Cuba, Mexico, Uruguay, Venezuela,
Canada, France, Germany, Japan, Spain, Sweden, UK and
USA), met in Pucón (23-26 October, 2006), in the beautiful
Chilean Lake District, for the 18th Latin American Congress
of Microbiology, organized by
the Latin American Association
for Microbiology (ALAM). The
congress was held in conjunc-
tion with the 28th Chilean Con-
gress of Microbiology, and the
3rd Chilean Congress of Food
Microbiology and Hygene. Prof.
Michael Seeger, president of the
Chilean Society for Microbiol-
ogy, chaired the meeting, which
was a great success.
What emerged from the
ALAM Meeting in Pucón was a
synthesis of the microbiological
opportunities and challenges for
Latin America and the Carib-
bean region for the coming dec-
ades. The growth of the Internet,
e-science, and wiki interactive
sites and sofwtare have provided
unprecedented opportunities for
collaborative research in many
areas of fundamental and applied
microbiology, to which Latin American scientists are clearly
responding. Also, the global nature of the threats posed by
new and re-emerging infectious diseases requires coopera-
tion that transcends borders. Because the Congress involved
so many issues of international concern, we believe that an
overview of the proceedings of the meeting could be of inter-
est to our colleagues outside Latin America. The participation
of the Spanish microbiologists was significant, and Prof.
Ricardo Guerrero, current president of the Spanish Society
for Microbiology (SEM), was invited to attend the ALAM
Assembly. There, several initiatives to establish permanent
cooperative relationships between ALAM and SEM were
discussed.
New and re-emerging diseases. As defined by the
US Centers for Disease Control and Prevention, new and re-
emerging diseases are “diseases of infectious origin whose
incidence in humans has increased within the past two
decades or threatens to increase in the near future”. They
include human and bovine tuberculosis, cholera, and han-
tavirus infections. Four two-hour symposia and a lecture
were devoted to discussing human and bovine tuberculosis
(TB). TB is the leading cause of death due to a single in-
fectious agent among adults in the world. Mycobacterium
tuberculosis is the most common cause of human TB, but
an unknown proportion of cases are due to M. bovis.
About 645,000 cases of human
TB were reported in Latin
America and the Caribbean
region in 2000 (up from
570,000 in 1990) but the actu-
al number is likely to be much
higher. In fact, many coun-
tries, especially those with few
resources, are unable to report
all TB cases due to difficulties
in identifying suspected cases,
establishing a diagnosis, and
recording cases. The incidence
of TB is especially high in
Peru (191 per 100,000 people)
and Bolivia (130 per 100,000)
compared to about 20–50 per
100,000 for many of the other
Latin American countries.
Industrialized countries typi-
cally report less than 20 cases
per 100,000. There is concern
that Peru and Bolivia represent
significant reservoirs of the
disease that can be spread by global activities. There is also
major concern that TB may be reemerging due to an increase
in the multidrug resistence of M. tuberculosis (topic covered
by P. Silva, Brazil), to the fact that it is increasing in HIV
compromised patients, and to the possibility that zoonotic TB
may emerge as a serious public health threat particularly in
countries such as Argentina, Paraguay and Uruguay, where
M. bovis infections are present in animals and the conditions
favor zoonotic transmission. Improved surveillance and the
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need to improve techniques for rapid diagnosis of TB were
pinpointed as critical issues. Many of the deaths caused by
TB in the developing world are due to wrong or late diagno-
sis. The technology needed to create more accurate and less
expensive tests already exists, however, and new tests could
easily be developed with funding. Above all, there is a great
need for tests that can detect latent TB and identify people at
high risk of developing the active disease. These topics were
discussed by many participants including E. Montoro (Cuba),
M-A. Telles (Brazil), A. Cataldi (Argentina), N. Morcillo (Ar-
gentina) and C. Martín (Spain). How the genome information
of M. bovis is being exploited for disease control was pre-
sented by S. Gordon (UK). A Latin American-European col-
laborative project concerning latency in M. tuberculosis was
described by M-J. García (Spain). 
Emerging or re-emerging problems associated with han-
tavirus infections, dengue fever, shigellosis, malaria and cho-
lera were covered in several posters. Recent advances in
understanding infections by Helicobacter were presented in a
session coordinated by A. Venegas (Chile). New strains of
influenza with pandemic potential (e.g., bird flu) and plans to
counteract a possible pandemic if they reach South America
were discussed in a session coordinated by L-F. Avendaño
(Chile).
The number of people living with HIV has risen to an esti-
mated 1.8 million [www.unaids.org/en/HIV_data/] in Latin
America, where the frequency is about 7 per 1000 adults. In
Haiti, the frequency is even higher, it nearly doubling that in
Latin America, with an estimated 13 per 1000 people infect-
ed. In the Caribbean, the AIDS epidemic claimed an estimat-
ed 24,000 lives in 2005, making it the leading cause of death
among adults aged 15–44 years in that region of the world.
Fundamental aspects of the molecular biology of HIV that
help in understanding its life cycle and in the design of vac-
cines were covered by M. López-Lastra (Chile), J-F Mous-
cadet (France) and V. Parissi (France). J-L Darlix (France)
discussed how HIV can hide in intracellular assembly parti-
cles avoiding immune surveillance and making vaccine
design particularly challenging. 
Increasing antifungal drug resistance, antibiotic
and antiviral resistance. Twelve Latin American and
Caribbean countries have taken concrete steps to curtail the
growth of antibiotic resistance, mainly through the creation
of surveillance systems. However, so far only Chile and
Cuba have implemented truly nationwide programs to curb
antibiotic resistance. Beginning in 1999, Chilean public
health authorities began enforcing local drug-dispensing
laws, complementing their efforts with a public information
campaign. 
Sessions were devoted to an analysis of the increasing
incidence of Candida infections (coordinator V. Silva, Chile),
and M. Valvano (Canada) gave a lecture regarding the mech-
anisms used by the Burkholderia cepacia group of organisms
to escape immune detection and to become resistant to mul-
tiple drugs. A session convened by R. Lagos (Chile) explored
the mechanisms exploited by microcins—small microbial
peptides—to kill susceptible competing bacteria. E. Calva
(Mexico) and G. Mora (Chile) discussed molecular aspects of
Salmonella enterica. There were also talks on horizontal
transfer of genes in nature via mobile genetic elements such
as phage and plasmids (S. Maloy, USA) and integrons (D.
Centrón, Argentina). 
Microbial biotechnology, genome biology and
bioinformatics. Issues related to biotechnological appli-
cations of microbiology were covered in sessions related to
salmon culture (convenor X. Fuentes, Chile), algal blooms
(convenor A. Cembella, Germany), decontamination of
pollutants (convenor M. Seeger, Chile), wine (convenor E.
Reyes, Chile) and biomining (convenor D.S. Holmes, Chile).
The microbiology of food was discussed in a number of ses-
sions and included an overview of residual antimicrobial
agents in food (B. San Martín, Chile). R. Conrad (Germany)
gave a lecture on methanogens and the production of the
greenhouse gas methane.
A course was given on phylogenetic approaches involv-
ing infectious microorganisms (F-M. de Campos Fernández)
and workshops were presented on annotating and interpreting
complete microbial genomes (D.S. Holmes and J. Valdés,
Chile) and on microbiology, biotechnology and sustainable
development (coordinators, M. Seeger and M. Espinoza,
Chile). A talk was presented by B. Wanner (USA) that
described new efforts to provide a comprehensive and coor-
dinated bioinformatics resource for Escherichia coli.
Biodiversity. Latin America is considered a major reser-
voir of biodiversity and is host to many extreme microbial
habitats. An overview of microbial diversity was presented
by R. Guerrero, Spain, and talks were given on unculturable
microorganisms (K-H. Schleifer, Germany), halophiles (R.
Rosselló-Mora, Spain) and extreme acid environments (J.
Banfield, USA). Efforts to preserve regional microbial diver-
sity in curated culture collections were described in a session
coordinated by M. Floccari (Argentina) and included an
overview of the accomplishments and objectives of the Latin
American Federation of Culture Collections (FELACC). 
Lacunae. Given the proportion of the Congress dedicated
to the important issue of new and emerging diseases, it was
MEETINGS
308 INT. MICROBIOL. Vol. 9, 2006
perhaps surprising to find no participants representing inter-
national public health organizations such as the World Health
Organization (WHO), the Pan-American Health Organiza-
tion (PAHO) or the US Centers for Disease Control (CDC),
who could have discussed the regional plans adopted by
Latin America for controlling emerging infections. Nor was
there discussion regarding the efforts put in place by the
Health authorities from Central American countries to con-
trol the epidemics of dengue fever and dengue hemorrhagic
fever that recently swept through Central and South America.
If we are to protect ourselves against emerging diseases, the
essential first step is effective global disease surveillance to
give early warning of emerging infections. This must be tied
to incentives such as national development, and eventually
be backed by a system for an appropriate rapid response.
World surveillance capabilities are critically deficient, and
experts from these agencies were absent from the ALAM
Congress. This lack of dialog meant that the important mes-
sages presented at the Congress did not reach the ears of
national or international policy makers and vice versa.
Cuba was the only Caribbean country represented at the
Congress, despite the critical microbiologically-related
issues of the region. Having said that, it was clear that the
meeting was a resounding success, not only for the excel-
lence and breadth of topics covered but in that it created new
networking opportunities and strengthened existing ones
both between Latin American countries and between Latin
America and the rest of the world. 
Highlight. A particular highlight of the four days was the
enthusiasm and quality of the many students who participat-
ed, many of them as first authors of most of the more than 350
posters. Many were able to attend thanks to the generous sup-
port of the Chilean National Commission for Scientific and
Technological Research (Conicyt) and the American Society
for Microbiology (ASM). There is clearly a bright future for
Latin American microbiology with these young people
chomping at the bit.
We apologize to all our colleagues whose important con-
tributions we could not cover due to space limitations. Further
information regarding the proceedings of the ALAM Con-
gress is provided by [www.alam2006.cl/] and additional infor-
mation about Latin American microbiology issues can be
found at the following resources online: 
Some Latin American microbiology resources
online: 
• SciDev.net (Science and Development Network for 
developing countries): [www.scidev.net]
• Ciencia hoy (Argentina): [www.cienciahoy.org.ar] 
• Interciencia (Venezuela): [www.interciencia.org]
• Jornal da Ciência (Brazil):
[www.jornaldaciencia.org.br/index2.jsp]
• Latíndex (Mexico): [www.latindex.unam.mx]
• SciELO (Scientific Electronic Library Online):
[www.scielo.org]
• Universia (Consortium of Latin American Universities):
[www.universia.net]
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Appendix. Articles on microbiology or scientific journals
in Latin America appeared in the SEM journals: 
• Schaechter M, Orrego C (1996) Microbiol SEM 12(1):7-8
• Ayala FJ (1996) Microbiol SEM 12(2):163-166
• Halvorson HO (1996) Microbiol SEM 12(3):343-346
• Colwell RR (1996) Microbiol SEM 12(4):519-522
• Cetto AM (1996) Microbiol SEM 12(4):647-650
• Lazcano A (1997) Microbiol SEM 13(1):7-10
• Allende JE (1997) Microbiol SEM 13(2):127-130
• González Cappa SM (1997) Microbiol SEM 13(3):267-270
• Toranzos GA (1997) Microbiol SEM 13(4):399-402
• Allende JE (1997) Microbiol SEM 13(4):529-532
• San-Blas G (1998) Int Microbiol 1(1):7-9
• Patarroyo MF (1998) Int Microbiol 1(2):89-91
• Cetto AM (1998) Int Microbiol 1(3):181-182
• Law C, Piqueras M (2000) Int Microbiol 3(4):253-258
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